Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fusion Medical

This article was originally published in The Gray Sheet

Executive Summary

Surgical sealant developer raises $8 mil. in a private equity placement with Alloy Ventures, the State of Wisconsin Investment Board, and the Asset Management Company. Proceeds will go toward commercialization of the firm's FloSeal and Proceed hemostatic sealants. Approximately 2.7 mil. shares were sold at $2.93 each, which is the average closing price of Fusion stock over the ten days preceding the April 9 completion of the financing. In addition, each investor received a warrant for the purchase of up to an additional 25% of the total shares purchased at $3.66 per share, or 125% of the purchase price



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts